scPharmaceuticals Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Scpharmaceuticals Inc. |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
Related Tickers: SCPH
TL;DR
SCPH Q1 2025 10-Q filed. Financials and operations detailed.
AI Summary
scPharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key financial data and business activities are disclosed, providing insights into the company's current standing and future outlook.
Why It Matters
This filing provides investors with crucial financial and operational data for scPharmaceuticals Inc. for the first quarter of 2025, enabling informed investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, scPharmaceuticals faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 20250514 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- scPharmaceuticals Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date
- Cowen and Company LLC (company) — Mentioned in relation to an ATM agreement
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001604950.
What is the Standard Industrial Classification (SIC) code for scPharmaceuticals Inc.?
The SIC code for scPharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of scPharmaceuticals Inc.?
The business address of scPharmaceuticals Inc. is 25 Burlington Mall Road, Suite 203, Burlington, MA 01803.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding scPharmaceuticals Inc..